PLIANT THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PLIANT THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2023-03-31 was $269.92M.
- PLIANT THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $215.40M.
- PLIANT THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2023 was $269.78M, a 25.25% increase from fiscal 2022.
- PLIANT THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2022 was $215.40M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-12-31 | $269.78M 10-K · filed 2025-03-03 | |
| 2023-03-31 | $269.92M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $215.40M 10-K · filed 2025-03-03 | |
| 2022-09-30 | $215.40M 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |